Search results for "metal-binding inhibitors"

showing 1 items of 1 documents

Frontiers of metal-coordinating drug design

2020

INTRODUCTION: The occurrence of metal ions in biomolecules is required to exert vital cellular functions. Metal-containing biomolecules can be modulated by small-molecule inhibitors targeting their metal-moiety. As well, the discovery of cisplatin ushered the rational discovery of metal-containing-drugs. The use of both drug types exploiting metal–ligand interactions is well established to treat distinct pathologies. Therefore, characterizing and leveraging metal-coordinating drugs is a pivotal, yet challenging, part of medicinal chemistry. AREA COVERED: Atomic-level simulations are increasingly employed to overcome the challenges met by traditional drug-discovery approaches and to compleme…

DrugaromataseComputer sciencemedia_common.quotation_subject1.1 Normal biological development and functioningChemistry PharmaceuticalCellular functionsCYP450Antineoplastic AgentsComputational biologyLigandsQM/MMArticleruthenium drug03 medical and health sciences0302 clinical medicinebreast cancerUnderpinning researchCoordination ComplexesRAPTADrug Discoverymetal-binding inhibitorsHumansComputer SimulationPharmacology & Pharmacy030304 developmental biologymedia_commonQM0303 health sciencesMetallodrugPharmacology and Pharmaceutical Sciencesmetallo-beta-lacatamasesMMprostate cancermolecular dynamicsChemistry5.1 PharmaceuticalsMetals030220 oncology & carcinogenesisDrug DesignPharmaceuticalGeneric health relevanceDevelopment of treatments and therapeutic interventions
researchProduct